Summary
Elevance Health, Inc. (then known as WellPoint, Inc.) filed an 8-K on May 31, 2007, to report significant changes in its executive leadership. The report details the immediate resignation of David C. Colby from his roles as Vice Chairman, Chief Financial Officer, and Executive Vice President, effective May 30, 2007. This abrupt departure marks a key leadership transition for the company. Following Mr. Colby's resignation, the Board of Directors swiftly appointed Wayne S. DeVeydt, previously the senior vice president and chief accounting officer, as the new Chief Financial Officer and Executive Vice President. Mr. DeVeydt brings substantial experience from his tenure at Pricewaterhouse Coopers LLP, where he served as a lead engagement partner for major healthcare and insurance companies. Investors should note the immediate nature of these changes and the background of the newly appointed CFO.
Key Highlights
- 1Effective May 30, 2007, David C. Colby resigned from his positions as Vice Chairman, Chief Financial Officer, and Executive Vice President of WellPoint, Inc.
- 2The resignation was requested and accepted by the Chairman, President, and CEO, Larry C. Glasscock, incoming President and CEO, Angela F. Braly, and the Board of Directors.
- 3Wayne S. DeVeydt has been appointed as the new Chief Financial Officer and Executive Vice President, effective immediately.
- 4Mr. DeVeydt, age 37, previously held the role of Senior Vice President and Chief Accounting Officer since March 2005.
- 5Prior to joining WellPoint, Mr. DeVeydt had extensive experience with Pricewaterhouse Coopers LLP, including serving as a lead engagement partner for large managed care and insurance companies.
- 6The company's press release announcing these executive changes is attached as Exhibit 99.1 to this filing.